Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models.
about
Activation of estrogen receptor-alpha by E2 or EGF induces temporally distinct patterns of large-scale chromatin modification and mRNA transcription.Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.
P2860
Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Understanding endocrine resist ...... ncer and novel in vitro models
@nl
Understanding endocrine resist ...... cer and novel in vitro models.
@ast
Understanding endocrine resist ...... cer and novel in vitro models.
@en
type
label
Understanding endocrine resist ...... ncer and novel in vitro models
@nl
Understanding endocrine resist ...... cer and novel in vitro models.
@ast
Understanding endocrine resist ...... cer and novel in vitro models.
@en
prefLabel
Understanding endocrine resist ...... ncer and novel in vitro models
@nl
Understanding endocrine resist ...... cer and novel in vitro models.
@ast
Understanding endocrine resist ...... cer and novel in vitro models.
@en
P2860
P356
P1476
Understanding endocrine resist ...... cer and novel in vitro models.
@en
P2093
Iain R Hutcheson
P2860
P2888
P304
P356
10.1186/BCR1289
P407
P50
P577
2005-07-18T00:00:00Z
P5875
P6179
1047505573